Clinical predictors at diagnosis of disabling pediatric Crohn's disease

Guillaume Savoye, Julia Salleron, Corinne Gower-Rousseau, Jean Louis Dupas, Gwénola Vernier-Massouille, Mathurin Fumery, Véronique Merle, Eric Lerebours, Antoine Cortot, Dominique Turck, Jean Louis Salomez, Marc Lemann, Jean Frédéric Colombel, Alain Duhamel

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Background: Identification of children with Crohn's disease (CD) at high risk of disabling disease would be invaluable in guiding initial therapy. Our study aimed to identify predictors at diagnosis of a subsequent disabling course in a population-based cohort of patients with pediatric-onset CD. Methods: Among 537 patients with pediatric CD diagnosed at <17 years of age, 309 (57%) with 5-year follow-up were included. Clinical and demographic factors associated with subsequent disabling CD were studied. Three definitions of disabling CD were used: Saint-Antoine and Liège Hospitals' definitions and a new pediatric definition based on the presence at maximal follow-up of: 1) growth delay defined by body mass index (BMI), weight or height lower than -2 SD Z score; and 2) at least one intestinal resection or two anal interventions. Predictors were determined using multivariate analyses and their accuracy using the kappa method considering a relevant value ≤yen;0.6. Results: According to the Saint-Antoine definition, the rate of disabling CD was 77% and predictors were complicated behavior and L1 location. According to the Liège definition, the rate was 37% and predictors included behavior, upper gastrointestinal disease, and extraintestinal manifestations. According to the pediatric definition, the rate of disabling CD was 15%, and predictors included complicated behavior, age <14, and growth delay at diagnosis. Kappa values for each combination of predictors were, respectively, 0.2, 0.3, and 0.2 and were nonrelevant. Conclusions: Clinical parameters at diagnosis are insufficient to predict a disabling course of pediatric CD. More complex models including serological and genetic biomarkers should be tested. (Inflamm Bowel Dis 2012;)

Original languageEnglish
Pages (from-to)2072-2078
Number of pages7
JournalInflammatory Bowel Diseases
Issue number11
StatePublished - Nov 2012
Externally publishedYes


  • Crohn's disease
  • Montreal classification
  • pediatric


Dive into the research topics of 'Clinical predictors at diagnosis of disabling pediatric Crohn's disease'. Together they form a unique fingerprint.

Cite this